EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Design and Analysis of Novel HEV Vaccine Variants and Evaluation of Two Selected Candidates in a Porcine Infection Model

Isabella Hrabal iD, Elmira Aliabadi, Saskia Weber iD, George Liam Ssebyatika, Thomas Krey, Cora M Holicki, Laura Schmid, Katja Dinkelborg, Charlotte Schröder, Christine Fast, Patrick Behrendt, Martin H Groschup und 1 weitere

Liver International · 2025

DOI: 10.1111/liv.70246 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, 2025. Verfasst von Isabella Hrabal und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Greifswald, Germany. Hauptthemen laut MEDLINE: Hepatitis E, Hepatitis E virus, Viral Hepatitis Vaccines, Swine Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HZI - Vaccine to inhibit Autochtonous transmission of Hepatitis E (VaccInATE) joined project in: Helmholtz Initialisierungs- und Vernetzungsfonds für Infektion….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Hepatitis E virus (HEV) poses a significant global health concern, with millions of annual infections and a notable impact on public health. Although HEV is the leading cause of acute viral hepatitis worldwide, there is a substantial lack of approved and licensed vaccines. In this study, we evaluated the efficacy of several protein‐ and DNA‐based vaccine candidates against HEV using a combined in vitro/in vivo workflow.

Methods

Corresponding vaccine candidates were produced, biochemically analysed and characterised. The general immunogenicity of suitable vaccine candidates was initially evaluated in a rabbit model. Resulting antibodies were assessed for their reactivity and neutralising efficiency. Finally, the most effective candidates were tested in a pig infection model using a prime‐boost vaccination regimen.

Results

Using this approach, we analysed a total of seven vaccine candidates and demonstrated that the two most promising candidates significantly reduced virus shedding in swine faecal samples after infection. However, no sterile immunity was achieved.

Conclusions

This study conducted a comprehensive analysis to establish a rational approach for post‐vaccination immune responses in pigs. The insights gained from this research are expected to significantly contribute to the development and evaluation of future vaccine candidates for pig herds, ultimately reducing viral dissemination among pigs and preventing HEV transmission from pigs to humans. These findings hold important translational value, offering a foundation for both improving animal health and safeguarding public health.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis EHepatitis E virusViral Hepatitis VaccinesSwine DiseasesAnimalsSwineRabbitsDisease Models, AnimalVirus SheddingVaccines, DNAFecesImmunogenicity, VaccineVaccination

Stichwörter der Autor:innen

animal modelhepatitis E virusin vitro characterisationpig infection modelvaccine

Substanzen

Viral Hepatitis VaccinesVaccines, DNA

Autor:innen und Institutionen

  • Institute for Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Greifswald, Germany.
  • Institute for Experimental Virology, TWINCORE, Centre for Experimental and Clinical Infection Research, Hannover, Germany.
  • Helmholz Center for Infection Research GmbH, Braunschweig, Germany.
  • Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald, Germany.
  • Institute of Biochemistry, University of Lübeck, Lübeck, Germany.
  • Erasmus MC, Department of Viroscience, Rotterdam, the Netherlands.

ORCID-Profile: Isabella Hrabal, Saskia Weber

Förderung

  • HZI - Vaccine to inhibit Autochtonous transmission of Hepatitis E (VaccInATE) joined project in: Helmholtz Initialisierungs- und Vernetzungsfonds für Infektion…

Zitieren

APA

Hrabal, I., Aliabadi, E., Weber, S., Ssebyatika, G. L., Krey, T., Holicki, C. M., Schmid, L., Dinkelborg, K., Schröder, C., Fast, C., Behrendt, P., Groschup, M. H., & Eiden, M. (2025). Design and Analysis of Novel HEV Vaccine Variants and Evaluation of Two Selected Candidates in a Porcine Infection Model. Liver International. https://doi.org/10.1111/liv.70246

Vancouver

Hrabal I, Aliabadi E, Weber S, Ssebyatika GL, Krey T, Holicki CM, et al. Design and Analysis of Novel HEV Vaccine Variants and Evaluation of Two Selected Candidates in a Porcine Infection Model. Liver International. 2025. doi:10.1111/liv.70246

BibTeX
@article{Hrabal2025,
  author = {Hrabal, Isabella and Aliabadi, Elmira and Weber, Saskia and Ssebyatika, George Liam and Krey, Thomas and Holicki, Cora M and Schmid, Laura and Dinkelborg, Katja and Schröder, Charlotte and Fast, Christine and Behrendt, Patrick and Groschup, Martin H and Eiden, Martin},
  title = {Design and Analysis of Novel HEV Vaccine Variants and Evaluation of Two Selected Candidates in a Porcine Infection Model},
  journal = {Liver International},
  year = {2025},
  doi = {10.1111/liv.70246}
}
Kostenlos starten →